THE LATINO CANCER INSTITUTE Trademark

Trademark Overview


On Tuesday, October 21, 2025, a trademark application was filed for THE LATINO CANCER INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the THE LATINO CANCER INSTITUTE trademark a serial number of 99454306. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 21, 2025. This trademark is owned by Ysabel Duron. The THE LATINO CANCER INSTITUTE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of Latinos with cancer. Was presidentially appointed (2023-Biden) to the National Cancer Advisory Board ( NCI), where Latino concerns are shared; presented to the Latino Congressional Caucus (2024) on Latino cancer issues and systemic barriers; keynoted at the American Association of Cancer Researchers (AACR) Baltimore Disparities Conference (2025); currently serves on the California Institute for Regenerative Medicine (CIRM), a taxpayer funded stem cell agency as a patient advocate.; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of cancer risk, diagnostics and treatment. To that end, TLCI is engaged in research with Stanford University's School of Medicine (liver disease study); UCSF and UC Davis (developing and deploying a breast cancer hereditary toolkit with FQHC's), Ge...
the latino cancer institute

General Information


Serial Number99454306
Word MarkTHE LATINO CANCER INSTITUTE
Filing DateTuesday, October 21, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAssociation services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of Latinos with cancer. Was presidentially appointed (2023-Biden) to the National Cancer Advisory Board ( NCI), where Latino concerns are shared; presented to the Latino Congressional Caucus (2024) on Latino cancer issues and systemic barriers; keynoted at the American Association of Cancer Researchers (AACR) Baltimore Disparities Conference (2025); currently serves on the California Institute for Regenerative Medicine (CIRM), a taxpayer funded stem cell agency as a patient advocate.; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of cancer risk, diagnostics and treatment. To that end, TLCI is engaged in research with Stanford University's School of Medicine (liver disease study); UCSF and UC Davis (developing and deploying a breast cancer hereditary toolkit with FQHC's), Georgetown (psychosocial support for breast cancer patients and their caregivers increasing patient quality care experience); Duke University (AI); a community engagement project with the Universities of New Mexico and Iowa.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, October 21, 2025
Primary Code035
First Use Anywhere DateFriday, January 5, 2018
First Use In Commerce DateFriday, January 5, 2018

Trademark Owner History


Party NameYsabel Duron
Party Type10 - Original Applicant
Legal Entity Type54 - NOT AVAILABLE
AddressSan Jose, CA 95112

Trademark Events


Event DateEvent Description
Tuesday, October 21, 2025NEW APPLICATION ENTERED
Tuesday, October 21, 2025APPLICATION FILING RECEIPT MAILED